119 related articles for article (PubMed ID: 6352601)
1. A comparison of azlocillin and ticarcillin in the treatment of complicated urinary tract infections.
Cox CE
J Antimicrob Chemother; 1983 May; 11 Suppl B():183-8. PubMed ID: 6352601
[TBL] [Abstract][Full Text] [Related]
2. Comparison of azlocillin and ticarcillin in the treatment of urinary tract infection.
Reed WP; Palmer DL
J Antimicrob Chemother; 1983 May; 11 Suppl B():189-93. PubMed ID: 6619028
[TBL] [Abstract][Full Text] [Related]
3. Timentin versus piperacillin in the treatment of hospitalized patients with urinary tract infections.
Cox CE
J Antimicrob Chemother; 1986 May; 17 Suppl C():93-6. PubMed ID: 3636340
[TBL] [Abstract][Full Text] [Related]
4. Clinical experience with azlocillin in the treatment of urinary tract infections with Pseudomonas aeruginosa.
Vestin L; Burman LA; Holm S; Sellers J
Scand J Infect Dis; 1982; 14(4):289-91. PubMed ID: 7163781
[TBL] [Abstract][Full Text] [Related]
5. Clinical and bacteriological responses to three antibiotic regimens for acute exacerbations of cystic fibrosis: ticarcillin-tobramycin, azlocillin-tobramycin, and azlocillin-placebo.
McLaughlin FJ; Matthews WJ; Strieder DJ; Sullivan B; Taneja A; Murphy P; Goldmann DA
J Infect Dis; 1983 Mar; 147(3):559-67. PubMed ID: 6339649
[TBL] [Abstract][Full Text] [Related]
6. Treatment with azlocillin in complicated urinary tract infections.
Alfthan O; Renkonen OV; Ohlsson H
Arzneimittelforschung; 1979; 29(12a):1979-81. PubMed ID: 543906
[TBL] [Abstract][Full Text] [Related]
7. Randomized, double-blind evaluation of azlocillin for the treatment of pulmonary exacerbations of cystic fibrosis.
McLaughlin FJ; Matthews WJ; Strieder DJ; Sullivan B; Goldmann DA
J Antimicrob Chemother; 1983 May; 11 Suppl B():195-203. PubMed ID: 6352602
[TBL] [Abstract][Full Text] [Related]
8. Treatment of serious Pseudomonas infections with azlocillin.
Olive S; Mogabgab WJ; Holmes B; Pollock B; Pauling B; Beville R
J Antimicrob Chemother; 1983 May; 11 Suppl B():153-8. PubMed ID: 6619026
[TBL] [Abstract][Full Text] [Related]
9. Comparative effectiveness, safety and tolerance of mezlocillin and ticarcillin: a prospective randomized trail.
Ramírez-Ronda CH; Gutiérrez J; Bermúdez RH
J Antimicrob Chemother; 1982 Jan; 9 Suppl A():125-9. PubMed ID: 6210660
[No Abstract] [Full Text] [Related]
10. Comparative study of ticarcillin plus clavulanate potassium versus piperacillin in the treatment of hospitalized patients with urinary tract infections.
Cox CE
Am J Med; 1985 Nov; 79(5B):88-90. PubMed ID: 4073101
[TBL] [Abstract][Full Text] [Related]
11. A comparison of azlocillin and gentamicin in the treatment of serious infections caused by Pseudomonas aeruginosa.
Gonzalez MA
J Antimicrob Chemother; 1983 May; 11 Suppl B():169-74. PubMed ID: 6352600
[TBL] [Abstract][Full Text] [Related]
12. [Evaluation of the clinical activity of azlocillin. A multicenter study conducted in 14 centers].
Konopka CA
Presse Med; 1984 Mar; 13(13):808-11. PubMed ID: 6231600
[TBL] [Abstract][Full Text] [Related]
13. A comparative study of the efficacy and safety of azlocillin and gentamicin in the treatment of serious infections.
del Rosal PL
J Antimicrob Chemother; 1983 May; 11 Suppl B():159-67. PubMed ID: 6352599
[TBL] [Abstract][Full Text] [Related]
14. Antimicrobial therapy of Pseudomonas pulmonary exacerbations in cystic fibrosis. A prospective evaluation of netilmicin plus azlocillin versus netilmicin plus ticarcillin.
Schaad UB; Desgrandchamps D; Kraemer R
Acta Paediatr Scand; 1986 Jan; 75(1):128-38. PubMed ID: 3082103
[TBL] [Abstract][Full Text] [Related]
15. Comparative study of mezlocillin and ticarcillin in the treatment of urinary tract infections.
Madsen PO; Nielsen OS
Clin Ther; 1980; 3(4):311-5. PubMed ID: 6456068
[TBL] [Abstract][Full Text] [Related]
16. [Current chemotherapy of infections caused by Pseudomonas aeruginosa (author's transl)].
Bauernfeind A; Petermüller C; Dietzel M
Infection; 1979; 7(1):21-6. PubMed ID: 422252
[TBL] [Abstract][Full Text] [Related]
17. Preoperative treatment with azlocillin in complicated urinary tract infections.
Alfthan O; Renkonen OV; Ohlsson H
Scand J Infect Dis Suppl; 1981; 29():98-101. PubMed ID: 6947409
[TBL] [Abstract][Full Text] [Related]
18. [Role of azlocillin in the treatment of Pseudomonas urinary infections].
Canton P
Presse Med; 1984 Mar; 13(13):830-3. PubMed ID: 6231606
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of single-agent therapy with azlocillin, ticarcillin, and amikacin and beta-lactam/amikacin combinations for treatment of Pseudomonas aeruginosa bacteremia in granulocytopenic rats.
Johnson DE; Thompson B
Am J Med; 1986 May; 80(5C):53-8. PubMed ID: 3636060
[TBL] [Abstract][Full Text] [Related]
20. Comparative evaluation of netilmicin-ticarcillin and tobramycin-ticarcillin in the treatment of serious systemic infections in elderly patients.
Jansen W; Schwarz A
Clin Ther; 1984; 7(1):112-20. PubMed ID: 6394127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
